Both anti-HK1 and anti-KLHL12 are present in ∼37.5 and 40% of PBC patients who are negative for AMA alone, or are combined AMA, gp210 and Sp100 negative, respectively (Reig et al., 2020). This evidence concerns the gene HK1 and primary biliary cholangitis.